Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP977912.RAfuhOJvAU466Nw9odWTARNx9ILhGiqy8QjYUU0GVDRR0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP977912.RAfuhOJvAU466Nw9odWTARNx9ILhGiqy8QjYUU0GVDRR0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP977912.RAfuhOJvAU466Nw9odWTARNx9ILhGiqy8QjYUU0GVDRR0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP977912.RAfuhOJvAU466Nw9odWTARNx9ILhGiqy8QjYUU0GVDRR0130_provenance.
- NP977912.RAfuhOJvAU466Nw9odWTARNx9ILhGiqy8QjYUU0GVDRR0130_assertion description "[The recommended treatment for patients infected with hepatitis C virus genotype 2 (HCV2) is pegylated interferon (peginterferon) and ribavirin for 24 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977912.RAfuhOJvAU466Nw9odWTARNx9ILhGiqy8QjYUU0GVDRR0130_provenance.
- NP977912.RAfuhOJvAU466Nw9odWTARNx9ILhGiqy8QjYUU0GVDRR0130_assertion evidence source_evidence_literature NP977912.RAfuhOJvAU466Nw9odWTARNx9ILhGiqy8QjYUU0GVDRR0130_provenance.
- NP977912.RAfuhOJvAU466Nw9odWTARNx9ILhGiqy8QjYUU0GVDRR0130_assertion SIO_000772 16956917 NP977912.RAfuhOJvAU466Nw9odWTARNx9ILhGiqy8QjYUU0GVDRR0130_provenance.
- NP977912.RAfuhOJvAU466Nw9odWTARNx9ILhGiqy8QjYUU0GVDRR0130_assertion wasDerivedFrom befree-20150227 NP977912.RAfuhOJvAU466Nw9odWTARNx9ILhGiqy8QjYUU0GVDRR0130_provenance.
- NP977912.RAfuhOJvAU466Nw9odWTARNx9ILhGiqy8QjYUU0GVDRR0130_assertion wasGeneratedBy ECO_0000203 NP977912.RAfuhOJvAU466Nw9odWTARNx9ILhGiqy8QjYUU0GVDRR0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP977912.RAfuhOJvAU466Nw9odWTARNx9ILhGiqy8QjYUU0GVDRR0130_provenance.